Sangamo Therapeutics
(SGMO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -26,417 | -26,624 | -22,264 | -35,750 | -24,854 |
| Depreciation Amortization | 1,647 | 1,481 | 1,549 | 2,222 | 1,863 |
| Accounts receivable | -7,298 | 860 | -3,273 | -547 | -293 |
| Other Working Capital | 9,665 | -545 | 7,172 | -448 | -8,761 |
| Other Operating Activity | 16,728 | 5,346 | 8,734 | 8,628 | 8,111 |
| Operating Cash Flow | $-5,675 | $-19,482 | $-8,082 | $-25,895 | $-23,934 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -100,037 | -67,765 | 12,042 | -19,423 | 13,069 |
| PPE Investments | N/A | -432 | -723 | -576 | -695 |
| Net Acquisitions | -621 | 79 | N/A | N/A | N/A |
| Investing Cash Flow | $-100,658 | $-68,118 | $11,319 | $-19,999 | $12,374 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 106,733 | 78,122 | 1,676 | 51,924 | 1,185 |
| Other Financing Activity | -4,556 | -2,015 | 0 | -48 | 0 |
| Financing Cash Flow | $102,177 | $76,107 | $1,676 | $51,876 | $1,185 |
| Beginning Cash Position | 10,186 | 21,679 | 16,766 | 10,784 | 21,159 |
| End Cash Position | 6,030 | 10,186 | 21,679 | 16,766 | 10,784 |
| Net Cash Flow | $-4,156 | $-11,493 | $4,913 | $5,982 | $-10,375 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,675 | -19,482 | -8,082 | -25,895 | -23,934 |
| Capital Expenditure | 0 | -432 | -723 | -576 | -695 |
| Free Cash Flow | -5,675 | -19,914 | -8,805 | -26,471 | -24,629 |